This suggests that CRG can alleviate NAFLD by inducing Bcl-2 expression to enhance mitophagy, and Bcl-2 can inhibit cell death by counteracting lipotoxicity. The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatotic liver disease.